States triple cartel claims against generic pharma
Credit: iStock/perkmeup
States pursuing claims of price fixing in the generic pharmaceutical industry asked a federal judge on Tuesday if they could amend the complaint to include 12 additional companies, 13 additional drugs and two senior executives to the list of defendants.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10